Christopher Stehn

6PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2026
The cell surface proteome of malignant peripheral nerve sheath tumors reveals therapeutic targets.

|Aug 05, 2026
DNA Hypomethylation Is Not Cell Intrinsically Toxic to Polycomb Repressive Complex 2 Deficient Malignant Peripheral Nerve Sheath Tumors.

|Apr 10, 2026
The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets.

Christopher M Stehn, Liangjun Wang, Zach Seeman

|Dec 02, 2024
Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.

Minu M Bhunia, Christopher M Stehn, Tyler A Jubenville

|Nov 06, 2023
Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression.

Gennie L Parkman, Tursun Turapov, David A Kircher

|Sep 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.

Aria Vaishnavi, Joseph Juan, Maebh Jacob

Pageof 1

Frequent Collaborators

4 joint publications

David A Largaespada

2 joint publications

Martin McMahon

1 joint publications

Gennie L Parkman

1 joint publications

Tursun Turapov